We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.38B
AUM Growth
+$66.8M
Cap. Flow
-$73.5M
Cap. Flow %
-2.18%
Top 10 Hldgs %
25.62%
Holding
354
New
31
Increased
99
Reduced
136
Closed
24

Top Buys

Rank Stock Value
1
PCOR icon
Procore
PCOR
+$38M
2
FLUT icon
Flutter Entertainment
FLUT
+$31.6M
3
SYNA icon
Synaptics
SYNA
+$10.5M
4
AAON icon
Aaon
AAON
+$8.88M
5
ROAD icon
Construction Partners
ROAD
+$8.04M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$26.7M
2
ARES icon
Ares Management
ARES
+$22.4M
3
MA icon
Mastercard
MA
+$10.9M
4
V icon
Visa
V
+$10.7M
5
AMZN icon
Amazon
AMZN
+$9.91M

Sector Composition

Rank Sector Weight
1 Technology 28.46%
2 Financials 15.72%
3 Healthcare 15.15%
4 Consumer Discretionary 13.81%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUPN icon
226
Supernus Pharmaceuticals
SUPN
$2.77B
$4.91M 0.15%
135,678
-63,974
-32% -$2.25M
KNSA icon
227
Kiniksa Pharmaceuticals
KNSA
$6.17B
$4.83M 0.14%
244,043
+4,361
+2% +$99.5K
SM icon
228
SM Energy
SM
$7.7B
$4.79M 0.14%
123,684
-4,461
-3% -$188K
MYGN icon
229
Myriad Genetics
MYGN
$301M
$4.7M 0.14%
342,845
+36,958
+12% +$682K
HZO icon
230
MarineMax
HZO
$1.15B
$4.48M 0.13%
154,605
+36,411
+31% +$1.12M
SPRY icon
231
ARS Pharmaceuticals
SPRY
$584M
$4.47M 0.13%
+423,561
New +$5.93M
ASTE icon
232
Astec Industries
ASTE
$974M
$4.45M 0.13%
132,510
-4,253
-3% -$147K
CHCT
233
Community Healthcare Trust
CHCT
$428M
$4.41M 0.13%
229,451
-8,319
-3% -$151K
MATV icon
234
Mativ Holdings
MATV
$695M
$4.4M 0.13%
+403,360
New +$5.62M
LGF.B
235
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$4.39M 0.13%
581,455
+10,414
+2% +$73K
CLW icon
236
Clearwater Paper
CLW
$365M
$4.33M 0.13%
+145,393
New +$3.94M
ONT
237
Onterris Inc
ONT
$569M
$4.29M 0.13%
231,393
+4,111
+2% +$86.5K
OGN icon
238
Organon & Co
OGN
$3.59B
$4.24M 0.13%
284,361
-9,897
-3% -$161K
ECPG icon
239
Encore Capital Group
ECPG
$2.03B
$4.18M 0.12%
87,530
-3,208
-4% -$152K
TMDX icon
240
Transmedics
TMDX
$3B
$4.12M 0.12%
66,140
+25,814
+64% +$2.4M
PRAA icon
241
PRA Group
PRAA
$712M
$3.88M 0.11%
185,587
-6,772
-4% -$145K
ANDE icon
242
Andersons Inc
ANDE
$2.21B
$3.84M 0.11%
94,891
-3,468
-4% -$161K
HELE icon
243
Helen of Troy
HELE
$679M
$3.47M 0.1%
58,048
+22,487
+63% +$1.49M
WGO icon
244
Winnebago Industries
WGO
$895M
$3.31M 0.1%
69,185
-2,537
-4% -$144K
FLWS icon
245
1-800-Flowers.com
FLWS
$256M
$3.07M 0.09%
375,730
-13,836
-4% -$111K
TITN icon
246
Titan Machinery
TITN
$425M
$2.9M 0.09%
205,324
-7,559
-4% -$109K
LSEA
247
DELISTED
Landsea Homes
LSEA
$2.89M 0.09%
+340,388
New +$3.67M
MANH icon
248
Manhattan Associates
MANH
$11.1B
$2.3M 0.07%
8,510
– –
GRDN
249
Guardian Pharmacy Services
GRDN
$2.5B
$2.29M 0.07%
113,075
-170,284
-60% -$3.52M
ULS icon
250
UL Solutions
ULS
$15.3B
$2.08M 0.06%
41,700
– –
8 9
10
11 12

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Peregrine Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Peregrine Capital Management held 354 positions worth $3.38B, up 2% from $3.31B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Peregrine Capital Management's Q4 2024 filing shows 31 new, 99 increased, 136 reduced and 24 closed positions. Its largest new stake was Procore: 535,699 shares worth $40.1M. The largest sale was Edwards Lifesciences, an estimated $26.7M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

  • Peregrine Capital Management's largest Q4 2024 buy was Procore: 535,699 shares worth $40.1M.
  • Peregrine Capital Management added most to Synaptics in Q4 2024, an estimated $10.5M increase.
  • Peregrine Capital Management's biggest Q4 2024 reduction was Ares Management, cutting an estimated $22.4M.
  • Peregrine Capital Management fully exited Edwards Lifesciences in Q4 2024, selling an estimated $26.7M.
  • Peregrine Capital Management's ten largest holdings make up 26% of its $3.38B portfolio in Q4 2024.
  • Peregrine Capital Management opened 31 new positions and closed 24 in Q4 2024.
  • Peregrine Capital Management's portfolio value rose 2% quarter-over-quarter to $3.38B.

Based on Peregrine Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.